4 services found
Burning Rock Biotech Limited Services
-
Biopharma Partner Sevices
Burning Rock focuses on providing comprehensive cancer genomic solutions for pharmaceutical companies from biomarker discovery to commercialization. Powered by our multi-dimensional genomic data from >250,000* cancer patients in China, multimodal central lab testing, integrated companion diagnostic development and commercialization, as well as precision patient recruitment, Burning Rock facillitates the entire process of anti-cancer drug development.
-
Genomic Data Solutions
Burning Rock utilizes our own proprietary large-scale genomic dataset based on personalized analyses of Chinese cancer patients*, ntegrates the experience from multi-dimensional clinical/scientific research and published data, to provide a one-stop cancer genomic data solution for biopharma partners, aiming to speed up precision drug development and reduce the risks. Burning Rock provides effective biomarker clinical trial strategies for ...
-
Central Lab Testing Services
Burning Rock offers integrated central lab services for biopharma partners, from multimodal sample testing to data analysis, meeting drug developing requirement, with four industry-leading qualifications (CLIA, CAP, NCCL, and NMPA) and full spectra of diagnostic products. So far, we have provided central lab services with >50 clinical research studies for >30 pharmaceutical companies, covering clinical study sites ...
-
CDx Development and Commercialization Services
Burning Rock offers integrated companion diagnostic development services for biopharma partners to streamline the co-development and commercialization of targeted drugs and respective CDx (including registration testing, clinical evaluation and finally obtain registration certificates. Our US-based lab and R&D team provide additional services to promote drug and CDx co-development ...
-
Precision Patient Recruitment Service
Burning Rock proprietary database intelligent screening system screens reports, and regularly identifies patients with rare or specific genetic ...